Skip to content
← Full study record

NCT04186819 · OUTCOME

The Percentage of Patients in Whom Planned RP Was Converted to EBRT. (Objective 6b)

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer. · Source last updated 2025-02-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage
Interval / dispersion
Not reported
Time frame
Conventional images within 60 days or at least 24 hours prior to rhPSMA-7.3 (18F) PET, followed by treatment within 60 days post IMP administration

Groups in this outcome

Extended Efficacy Population (EEP)

all patients who received rhPSMA-7.3 (18F) injection followed by a PET scan. This population included M0 and M1 patients independent of performance of RP and PLND and was used for M1 related efficacy and Kappa statistics.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Extended Efficacy Population (EEP)352

Reported measurements

Source class 1
Values in percentage · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Extended Efficacy Population (EEP)2.6Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        2.6
denoms
  1. counts
    1. group Id
      OG000
      value
      352
    units
    Participants
groups
  1. description
    all patients who received rhPSMA-7.3 (18F) injection followed by a PET scan. This population included M0 and M1 patients independent of performance of RP and PLND and was used for M1 related efficacy and Kappa statistics.
    id
    OG000
    title
    Extended Efficacy Population (EEP)
param Type
NUMBER
reporting Status
POSTED
time Frame
Conventional images within 60 days or at least 24 hours prior to rhPSMA-7.3 (18F) PET, followed by treatment within 60 days post IMP administration
title
The Percentage of Patients in Whom Planned RP Was Converted to EBRT. (Objective 6b)
type
SECONDARY
unit Of Measure
percentage

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice